STOCK TITAN

Ventyx Biosciences, Inc. (VTYX) EPS by Year

VTYX

Ventyx Biosciences, Inc. lost $1.97 per diluted share in fiscal year 2024. This represents an increase of 40.3% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $1.50 per diluted share. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Ventyx Biosciences, Inc. has filed alongside them.

FY2024 annual
EPS (Diluted) -$1.97
YoY +40.3%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VTYX EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
EPS (Diluted)-$1.50-$1.97+40.3%-$3.30-59.4%-$2.07-$6.65N/A

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

VTYX EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
EPS (Diluted)-$0.32+36.0%-$0.38+24.0%-$0.39+37.1%-$0.41+48.1%-$0.50+45.7%-$0.50+45.1%-$0.62+8.8%-$0.79-23.4%-$0.92-55.9%-$0.91-133.3%-$0.68-51.1%-$0.64-104.9%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Ventyx Biosciences, Inc. financials

Frequently Asked Questions

What was Ventyx Biosciences, Inc.'s diluted earnings per share in fiscal year 2024?

Ventyx Biosciences, Inc. lost $1.97 per diluted share in fiscal year 2024.

How fast is Ventyx Biosciences, Inc.'s diluted earnings per share growing?

Ventyx Biosciences, Inc. (VTYX) diluted earnings per share rose by 40.3% year over year, from -$3.30 to -$1.97 in fiscal year 2024.

What is Ventyx Biosciences, Inc.'s diluted earnings per share over the last twelve months?

Ventyx Biosciences, Inc. (VTYX) reported a loss of $1.50 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Ventyx Biosciences, Inc. (VTYX) reported -$0.32 in diluted earnings per share in Q3 2025. This represents an increase of 36.0% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Ventyx Biosciences, Inc. (VTYX) reported on that line in every period on record.